BridgeBio Pharma, Inc.BBIONASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-123.98%
↑ 94% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-2004.34%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -123.98% | +37.0% |
| 2024 | -196.86% | +96.8% |
| 2023 | -6078.34% | -1087.5% |
| 2022 | -511.85% | +33.2% |
| 2021 | -765.73% | +86.5% |
| 2020 | -5665.86% | -723.8% |
| 2019 | -687.77% | - |